[Form 4] CNO Financial Group, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CNO Financial Group General Counsel Matthew J. Zimpfer reported option exercises and related stock sales. On February 17 and 18, 2026, he exercised employee stock options covering 57,370 shares of common stock and acquired the same number of shares through derivative exercises.
On those same dates, he sold a total of 57,370 shares of CNO common stock in open-market transactions at weighted average prices of $43.1656 and $43.0515 per share, pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. Following these transactions, he directly owned 307,937 shares of CNO common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 57,370 shares ($2,472,554)
Net Sell
6 txns
Insider
Zimpfer Matthew J.
Role
General Counsel
Sold
57,370 shs ($2.47M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 33,800 | $0.00 | -- |
| Exercise | Common Stock | 33,800 | $17.48 | $591K |
| Sale | Common Stock | 33,800 | $43.0515 | $1.46M |
| Exercise | Employee Stock Option (Right to Buy) | 23,570 | $0.00 | -- |
| Exercise | Common Stock | 23,570 | $23.33 | $550K |
| Sale | Common Stock | 23,570 | $43.1656 | $1.02M |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 341,737 shares (Direct)
Footnotes (1)
- Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.92 per share to $43.28 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. One-half of the stock options vested and became exercisable on February 21, 2020, and one-half vested and became exercisable on February 21, 2021. One-half of the stock options vested and became exercisable on February 19, 2021, and one-half vested and became exercisable on February 19, 2022.